ATE475097T1 - Erkennung von tumor-spezifischen genprodukten bei krebs - Google Patents

Erkennung von tumor-spezifischen genprodukten bei krebs

Info

Publication number
ATE475097T1
ATE475097T1 AT01995819T AT01995819T ATE475097T1 AT E475097 T1 ATE475097 T1 AT E475097T1 AT 01995819 T AT01995819 T AT 01995819T AT 01995819 T AT01995819 T AT 01995819T AT E475097 T1 ATE475097 T1 AT E475097T1
Authority
AT
Austria
Prior art keywords
detection
tumor
specific gene
gene products
cancer
Prior art date
Application number
AT01995819T
Other languages
English (en)
Inventor
Dongen Jacobus Van
Der Velden Vincent Van
Original Assignee
Univ Erasmus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Erasmus filed Critical Univ Erasmus
Application granted granted Critical
Publication of ATE475097T1 publication Critical patent/ATE475097T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82—Translation products from oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
AT01995819T 2000-12-29 2001-12-28 Erkennung von tumor-spezifischen genprodukten bei krebs ATE475097T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/752,635 US6686165B2 (en) 1997-05-20 2000-12-29 Recognition of tumor-specific gene products in cancer
PCT/NL2001/000945 WO2002054074A2 (en) 2000-12-29 2001-12-28 Recognition of tumor-specific gene products in cancer

Publications (1)

Publication Number Publication Date
ATE475097T1 true ATE475097T1 (de) 2010-08-15

Family

ID=25027138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01995819T ATE475097T1 (de) 2000-12-29 2001-12-28 Erkennung von tumor-spezifischen genprodukten bei krebs

Country Status (10)

Country Link
US (1) US6686165B2 (de)
EP (1) EP1348126B1 (de)
JP (1) JP2004523740A (de)
CN (1) CN1493000A (de)
AT (1) ATE475097T1 (de)
AU (1) AU2002226810B2 (de)
CA (1) CA2433556A1 (de)
DE (1) DE60142634D1 (de)
ES (1) ES2348706T3 (de)
WO (1) WO2002054074A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0878552A1 (de) * 1997-05-13 1998-11-18 Erasmus Universiteit Rotterdam Molekularer Nachweis von chromosomalen Veränderungen
AU3516899A (en) * 1998-05-04 1999-11-23 Dako A/S Method and probes for the detection of chromosome aberrations
ES2352050T3 (es) * 2002-11-07 2011-03-18 Erasmus Universiteit Rotterdam Método y sondas para la detección de una proteína de fusión específica de un tumor.
WO2004050870A2 (en) * 2002-12-05 2004-06-17 Ludwig-Maximilians-Uni Versität Genetic switches for the detection of fusion proteins
EP1507147A1 (de) * 2003-08-12 2005-02-16 Erasmus University Medical Center Rotterdam Verfahren zum Nachweiss von niedrigem Gehalt an Fusionsprotein
US20050214301A1 (en) * 2004-03-24 2005-09-29 Cell Signaling Technology, Inc. Antibodies specific for BCR-ABL fusion protein and uses thereof
DE212006000071U1 (de) 2005-11-18 2008-07-24 Board of Regents, The University of Texas System, Austin Quantifizierung von Fusionsproteinen und ihrer Aktivität in Folge chromosomaler Translokation
EP2108956A1 (de) * 2008-04-07 2009-10-14 Erasmus University Medical Center Rotterdam Verbesserte Verfahren und Kits zum Erkennen von tumorspezifischen Fusionsproteinen
JP5819307B2 (ja) 2009-10-20 2015-11-24 ネステク ソシエテ アノニム 発癌性融合タンパク質を検出するための近接媒介性アッセイ
US9034658B2 (en) * 2009-11-23 2015-05-19 The General Hospital Corporation Microfluidic devices for the capture of biological sample components
US20120065092A1 (en) * 2010-09-14 2012-03-15 Wai Hobert Fusion analyte cytometric bead assay, and systems and kits for performing the same
KR101479543B1 (ko) 2013-03-15 2015-01-07 서강대학교산학협력단 Ｔｆｇ－ｔｅｃ 융합 컨스트럭트를 이용한 종양 질환의 예방 또는 치료용 물질의 스크리닝 방법 및 이의 용도
JP2018184369A (ja) * 2017-04-26 2018-11-22 株式会社明治 知的作業能力向上用組成物および認知能力向上用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
US4788138A (en) * 1987-04-30 1988-11-29 Beckman Instruments, Inc. Method to achieve a linear standard curve in a sandwich immunoassay
NO164622C (no) * 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
CA2025563A1 (en) * 1989-01-19 1990-07-20 Kenji Hosoda Immunological assaying method, reagent and kit therefor
AU6882791A (en) 1989-11-22 1991-06-13 Children's Hospital Of Los Angeles Bcr/abl transgenic animals as models for philadelphia chromosome positive chronic myelogenous and acute lymphoblastic leukemia
WO1992021032A1 (en) * 1991-05-24 1992-11-26 The Regents Of The University Of California Methods for the detection of bcr-abl and abnormal abl proteins in leukemia patients
FR2691475B1 (fr) * 1992-05-20 1995-03-24 Centre Nat Rech Scient Séquence d'ADN des produits de fusion résultant de la translocation chromosomique récurrente t(11;22) (q24;q12) associée au développement d'un groupe de tumeurs cancéreuses.
US5667981A (en) 1994-05-13 1997-09-16 Childrens Hospital Of Los Angeles Diagnostics and treatments for cancers expressing tyrosine phosphorylated CRKL protein
DE4444969C1 (de) 1994-12-16 1996-10-24 Orga Med Dr Med Erwin Klopfer Nachweis von Antikörpern gegen p53 in Körperflüssigkeiten
US6159748A (en) * 1995-03-13 2000-12-12 Affinitech, Ltd Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry
DE69822149T2 (de) * 1997-05-20 2005-03-03 Erasmus Universiteit Rotterdam Erkennung von tmorspezifische genprodukte
US6150110A (en) * 1998-02-28 2000-11-21 The Brigham And Women's Hospital, Inc. HMGI(Y)-LAMA4* fusion oncogene, oncoprotein and methods of use

Also Published As

Publication number Publication date
EP1348126B1 (de) 2010-07-21
WO2002054074A2 (en) 2002-07-11
ES2348706T3 (es) 2010-12-13
AU2002226810B2 (en) 2007-05-10
US20020042056A1 (en) 2002-04-11
DE60142634D1 (de) 2010-09-02
JP2004523740A (ja) 2004-08-05
US6686165B2 (en) 2004-02-03
WO2002054074A3 (en) 2003-01-23
EP1348126A2 (de) 2003-10-01
CA2433556A1 (en) 2002-07-11
CN1493000A (zh) 2004-04-28

Similar Documents

Publication Publication Date Title
Hartjes et al. Extracellular vesicle quantification and characterization: common methods and emerging approaches
US20210170411A1 (en) Selective delivery of material to cells
Magnusson et al. Clinical-scale cell-surface-marker independent acoustic microfluidic enrichment of tumor cells from blood
ATE475097T1 (de) Erkennung von tumor-spezifischen genprodukten bei krebs
Hilton et al. Advances in the analysis of single extracellular vesicles: A critical review
ATE445841T1 (de) Verfahren zur spezifischen detektion von tumorzellen und ihren vorstufen in gebärmutterhalsabstrichen durch simultane messung von mindestens 2 verschiedenen molekularen markern
AU2014204426B2 (en) Integrated nucleic acid analysis
FI20020355A0 (fi) Reagenssi ja prosessi biologisten solujen identifioimiseksi ja laskemiseksi
SG165300A1 (en) Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates
BR9916840A (pt) Sistema de detecção biológica portátil integrado
WO2002086448A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
ATE466930T1 (de) Universelles sammelmedium
ATE544070T1 (de) Verfahren zum nachweis von tumorspezifischen fusionsproteinen
DK0983510T3 (da) Genkendelse af tumorspecifikke genprodukter i cancer
DE602005027699D1 (de) Nachweis von chromosomalen anormalitäten in aus follikularer flüssigkeit erhaltenen zellen
Zhao et al. Application of the Ludox-QPS method for estimating ciliate diversity in soil and comparison with direct count and DNA fingerprinting
Geethalakshmi et al. Utilization of flow cytometry in nanomaterial/bionanomaterial detection
Love Micro-and nanosystems for biotechnology
Li Cytometry of Single Cell in Biology and Medicine
Tiirikainen Detection of intracellular antigens by flow cytometry: Evaluation of a new permeabilization method for the detection of intracellular antigens in hematological malignancies.
Hsieh et al. Location and biomarker characterization of circulating tumor cells
ES2188384A1 (es) Procedimiento de obtencion de adn humano a partir de fluido crevicular gingival.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties